Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | Director | September 30, 2024 | October 02, 2024 |
| Generate Biomedicines, Inc.GENB · Entity 1553 | Director | February 26, 2026 | March 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date September 30, 2024 · Filed October 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 978 |
Reported balance
After 2024-09-30 transaction · row 1
1 source rowRow 1 · 2024-09-30 · Grant · Acquired 80 · Balance 978 F1: Receipt of Common Stock in lieu of portion of quarterly director's fee. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,280.6315 |
Reported balance
After 2024-08-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-08-30 · Grant · Acquired 25.0885 · Balance 3,280.6315 F2: 1-for-1 F3: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: Receipt of Common Stock in lieu of portion of quarterly director's fee.
F2: 1-for-1
F3: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
Generate Biomedicines, Inc.
Report date February 26, 2026 · Filed March 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2036-02-25 | Direct | 29,561 |
Reported balance
After 2026-02-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-26 · Grant · Acquired 29,561 · Balance 29,561 F1: The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2026 Filed Mar 2, 2026 17:45 UTC | Generate Biomedicines, Inc. GENB · Entity 1553 | GrantStock Option (Right to Buy) · Derivative | 29,561 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001193125-26-085861 · ownership.xml · derivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,561 Underlying: Common Stock · 29,561 shares Expires 2036-02-25 F1 · derivative.exercise_date: The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 22:32 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 80 | $162.91 | $13,032.80 |
DisclosureSEC source: 0001225208-24-009054 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 978 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| August 30, 2024 Filed Oct 2, 2024 22:32 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 25.0885 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009054 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,280.6315 Underlying: Common Stock · 25.0885 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:37 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 96 | $136.47 | $13,101.12 |
DisclosureSEC source: 0001225208-24-007231 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 898 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| May 10, 2024 Filed Jul 2, 2024 20:37 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 27.0263 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-007231 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,255.543 Underlying: Common Stock · 27.0263 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 22:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 85 | $153.11 | $13,014.35 |
DisclosureSEC source: 0001225208-24-004834 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 802 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| February 09, 2024 Filed Apr 2, 2024 22:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 25.0921 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004834 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,228.5167 Underlying: Common Stock · 25.0921 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,117.3538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000249 · doc4.xml · derivative · entry 3 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,203.4246 Underlying: Common Stock · 1,117.3538 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F5 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 92 | $142.59 | $13,118.28 |
DisclosureSEC source: 0001225208-24-000249 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 717 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| November 09, 2023 Filed Jan 3, 2024 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 18.7484 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000249 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,086.0708 Underlying: Common Stock · 18.7484 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 98 | $131.06 | $12,843.88 |
DisclosureSEC source: 0001225208-23-009226 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| August 25, 2023 Filed Oct 3, 2023 20:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 15.9301 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009226 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,067.3224 Underlying: Common Stock · 15.9301 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 80 | $159.04 | $12,723.20 |
DisclosureSEC source: 0001225208-23-007232 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| May 12, 2023 Filed Jul 5, 2023 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 14.2132 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-007232 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,051.3923 Underlying: Common Stock · 14.2132 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 81 | $158.24 | $12,817.44 |
DisclosureSEC source: 0001225208-23-004532 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| February 10, 2023 Filed Apr 4, 2023 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 15.8473 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004532 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,037.1792 Underlying: Common Stock · 15.8473 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,073.3191 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000266 · doc4.xml · derivative · entry 3 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,021.3319 Underlying: Common Stock · 1,073.3191 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F5 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 55 | $140.33 | $7,718.15 |
DisclosureSEC source: 0001225208-23-000266 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| November 10, 2022 Filed Jan 4, 2023 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 7.7064 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000266 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 948.0129 Underlying: Common Stock · 7.7064 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 60 | $128.39 | $7,703.40 |
DisclosureSEC source: 0001225208-22-010690 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| August 12, 2022 Filed Oct 4, 2022 20:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 7.5199 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010690 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 940.3065 Underlying: Common Stock · 7.5199 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 54 | $140.98 | $7,612.92 |
DisclosureSEC source: 0001225208-22-008519 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| May 13, 2022 Filed Jul 5, 2022 20:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 6.7865 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008519 · doc4.xml · derivative · entry 3 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932.7866 Underlying: Common Stock · 6.7865 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 55 | $139.03 | $7,646.65 |
DisclosureSEC source: 0001225208-22-005403 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197 F1 · security: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| February 11, 2022 Filed Jul 5, 2022 20:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 7.3978 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008519 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 926.0001 Underlying: Common Stock · 7.3978 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 918.6024 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000185 · doc4.xml · derivative · entry 2 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918.6024 Underlying: Common Stock · 918.6024 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 36 | $174.36 | $6,276.96 |
DisclosureSEC source: 0001225208-22-000185 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 38 | $165.61 | $6,293.18 |
DisclosureSEC source: 0001225208-21-012806 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-010105 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee pursuant to the Independent Directors' Stock- Based Compensation Plan. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 20:51 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 33 | $192.88 | $6,365.04 |
DisclosureSEC source: 0001225208-21-006340 · doc4.xml · nonDerivative · entry 1 Parker Paul Gray · CIK 0001833033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 F1 · kind: Receipt of Common Stock in lieu of portion of quarterly director's fee pursuant to the Independent Directors' Stock- Based Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.